This robotics startup raised $75 million to automate drug manufacturing. See the pitch deck.
A robotics startup raised $75 million to automate manufacturing for complex medicines. See the pitch deck it used.
Multiply Labs, a robotics startup based in San Francisco, has raised $75 million in a Series B funding round to automate drug manufacturing. The company, led by CEO Fred Parietti, builds robots for manufacturing complex drugs like gene therapies and mRNA treatments. The funding round was led by NantWorks, with investors including AstraZeneca, Lux Capital, and Founders Fund.
Multiply's robots are large, long boxes packed with test tubes and robotic arms, and the company has deployed its machines with a small group of customers. The company's pitch deck highlights how it plans to solve the issue of making complex drugs, which is still largely done manually in laboratories, a process that is slow, difficult to scale, and vulnerable to human error and contamination.
Brief written by urgent.news from Business Insider's own syndicated text. Machine-written — may contain errors; check the original before relying on it.
